{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:32:22Z","timestamp":1792103542299,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.suronc.2020.05.006","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T19:29:04Z","timestamp":1591212544000},"page":"270-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis"],"prefix":"10.1016","volume":"34","author":[{"given":"Andrea","family":"Di Giorgio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Alberto","family":"Schena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam Attalla","family":"El Halabieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Abatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Strippoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frediano","family":"Inzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rodolfino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Roman\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Pacelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Rotolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.suronc.2020.05.006_bib1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.ejso.2010.09.006","article-title":"Surgical treatment for peritoneal carcinomatosis from gastric cancer","volume":"36","author":"Yonemura","year":"2010","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.suronc.2020.05.006_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1470-2045(15)00553-7","article-title":"Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial","volume":"17","author":"Fujitani","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.suronc.2020.05.006_bib3","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ijc.28373","article-title":"Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors","volume":"134","author":"Thomassen","year":"2014","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.suronc.2020.05.006_bib4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4613-1247-5_4","article-title":"Peritoneal-plasma barrier","volume":"82","author":"Jacquet","year":"1996","journal-title":"Canc. Treat Res."},{"issue":"7","key":"10.1016\/j.suronc.2020.05.006_bib5","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","article-title":"Description of a novel approach for intraperitoneal drug delivery and the related device","volume":"26","author":"Solass","year":"2012","journal-title":"Surg. Endosc."},{"issue":"2","key":"10.1016\/j.suronc.2020.05.006_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1515\/pp-2016-0011","article-title":"Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS)","volume":"1","author":"Solass","year":"2016","journal-title":"Pleura and Peritoneum"},{"issue":"19","key":"10.1016\/j.suronc.2020.05.006_bib7","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1200\/JCO.2018.77.8613","article-title":"Phase III trial comparing intraperitoneal and intravenous paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC trial","volume":"36","author":"Ishigami","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.suronc.2020.05.006_bib8","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.18.01688","article-title":"Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis","volume":"37","author":"Bonnot","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.suronc.2020.05.006_bib9","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00432-016-2234-0","article-title":"Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model","volume":"142","author":"Khosrawipour","year":"2016","journal-title":"J. Canc. Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2020.05.006_bib10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/DCR.0000000000001565","article-title":"Pressurized intraperitoneal aerosol chemotherapy, a palliative treatment approach for patients with peritoneal carcinomatosis: description of method and systematic review of literature","volume":"63","author":"Winkler","year":"2020","journal-title":"Dis. Colon Rectum"},{"issue":"2","key":"10.1016\/j.suronc.2020.05.006_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11605-015-2995-9","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with low-dose cisplatin and doxorubicin in gastric peritoneal metastasis","volume":"20","author":"Nadiradze","year":"2016","journal-title":"J. Gastrointest. Surg."},{"issue":"3","key":"10.1016\/j.suronc.2020.05.006_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1515\/pp-2016-0017","article-title":"Bidirectional chemotherapy in gastric cancer with peritoneal metastasis combining intravenous XELOX with intraperitoneal chemotherapy with low-dose cisplatin and doxorubicin administered as a pressurized aerosol: an open-label, phase-2 study (PIPAC-GA2)","volume":"1","author":"Khomyakov","year":"2016","journal-title":"Pleura and Peritoneum"},{"issue":"4","key":"10.1016\/j.suronc.2020.05.006_bib13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5230\/jgc.2018.18.e37","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in gastric cancer patients with peritoneal metastasis (PM): results of a single-center experience and register study","volume":"18","author":"Gockel","year":"2018","journal-title":"J Gastric Cancer"},{"key":"10.1016\/j.suronc.2020.05.006_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919846402","article-title":"Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C\/D) in patients with gastric cancer and peritoneal metastasis: a phase II study","volume":"11","author":"Struller","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2020.05.006_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ygyno.2015.02.009","article-title":"Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study","volume":"137","author":"Tempfer","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2020.05.006_bib16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/codi.13130","article-title":"Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis","volume":"18","author":"Demtr\u00f6der","year":"2016","journal-title":"Colorectal Dis."},{"issue":"5","key":"10.1016\/j.suronc.2020.05.006_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10585-017-9849-7","article-title":"Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"34","author":"Graversen","year":"2017","journal-title":"Clin. Exp. Metastasis"},{"issue":"7","key":"10.1016\/j.suronc.2020.05.006_bib18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10585-018-9925-7","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastases of pancreas and biliary tract cancer","volume":"35","author":"Horvath","year":"2018","journal-title":"Clin. Exp. Metastasis"},{"issue":"2","key":"10.1016\/j.suronc.2020.05.006_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00404-018-4784-7","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal carcinomatosis: systematic review of clinical and experimental evidence with special emphasis on ovarian cancer","volume":"298","author":"Tempfer","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"issue":"7","key":"10.1016\/j.suronc.2020.05.006_bib20","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.suronc.2020.05.006_bib21","first-page":"1","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) of peritoneal metastasis from gastric cancer: a descriptive cohort study","author":"Elleb\u00e6k","year":"2020","journal-title":"Clin. Exp. Metastasis"},{"issue":"7","key":"10.1016\/j.suronc.2020.05.006_bib22","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ejso.2015.03.231","article-title":"Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis","volume":"41","author":"Coccolini","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.suronc.2020.05.006_bib23","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1245\/s10434-015-5081-3","article-title":"Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility?","volume":"23","author":"Chia","year":"2016","journal-title":"Ann. Surg Oncol."},{"issue":"11","key":"10.1016\/j.suronc.2020.05.006_bib24","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.ejso.2018.06.036","article-title":"Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis","volume":"44","author":"Rihuete Caro","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2020.05.006_bib25","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.ejso.2018.10.085","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for nonresectable peritoneal metastasis","volume":"45","author":"Alyami","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2020.05.006_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12957-016-1008-0","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"14","author":"Girshally","year":"2016","journal-title":"World J. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.suronc.2020.05.006_bib27","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.ejso.2017.09.010","article-title":"Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis","volume":"43","author":"Alyami","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.suronc.2020.05.006_bib28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/bjs.10521","article-title":"Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis","volume":"104","author":"Grass","year":"2017","journal-title":"Br. J. Surg."},{"issue":"4","key":"10.1016\/j.suronc.2020.05.006_bib29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.23736\/S0026-4806.19.06081-6","article-title":"From palliation to cure: PIPAC for peritoneal malignancies","volume":"110","author":"Di Giorgio","year":"2019","journal-title":"Minerva Med."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096074042030325X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096074042030325X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T03:20:06Z","timestamp":1760757606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096074042030325X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":29,"alternative-id":["S096074042030325X"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2020.05.006","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2020.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}